MyGo, LLC v. Mission Beach Industries, LLC et al
Filing
25
ORDER Denying Defendant's 21 Motion to Stay. Signed by Judge Gonzalo P. Curiel on 1/31/17. (dlg)
1
2
3
4
5
6
7
8
UNITED STATES DISTRICT COURT
9
SOUTHERN DISTRICT OF CALIFORNIA
10
11
MYGO, LLC, a California corporation,
Case No.: 3:16-CV-2350-GPC-RBB
Plaintiff,
12
13
v.
ORDER DENYING DEFENDANT’S
MOTION TO STAY
14
MISSION BEACH INDUSTRIES, LLC,
a California corporation,
[ECF No. 21.]
15
Defendant.
16
17
18
19
20
21
22
23
24
25
Before the Court is Defendant and Counterclaimant Mission Beach Industries,
LLC’s (“Defendant’s” or “MBI’s”) motion to stay pending ex parte reexamination of
United States Patent No. 9,383,630 (“the ‘630 Patent”). (Dkt. No. 21.1) Plaintiff and
Counterdefendant MyGo, LLC (“Plaintiff” or “MyGo”) does not oppose the motion.
(Dkt. No. 23.) The Court deems Defendant’s motion suitable for disposition without oral
argument pursuant to Civil Local Rule 7.1(d)(1). Having reviewed the moving papers
and the applicable law, and for the reasons set forth below, the Court DENIES
Defendant’s motion to stay.
26
27
28
1
All citations to the record are based upon pagination generated by the CM/ECF system.
1
3:16-CV-2350-GPC-RBB
1
BACKGROUND
2
In a previous order, the Court recited the facts of this case at length and will
3
therefore not repeat them here. (See Dkt. No. 24.) The relevant procedural background
4
follows.
5
On September 16, 2016, MyGo filed a Complaint against MBI asserting, among
6
other allegations, infringement of its ‘630 Patent. (Dkt. No. 1.) On October 17, 2016,
7
MBI filed an Answer with counterclaims and affirmative defenses, including assertions
8
of patent invalidity. (Dkt. No. 7.) On December 12, 2016, MBI filed a request for ex
9
parte reexamination of the ‘630 Patent with the United States Patent and Trademark
10
Office (“PTO”) pursuant to 35 U.S.C. § 302 et seq. and 37 C.F.R. § 1.510 et seq. (Dkt.
11
No. 21-1 at 9:10–16.) To the Court’s knowledge, the PTO has not yet responded to this
12
initial request.2 (See id.) On December 13, 2016, MBI filed the instant motion to stay
13
pending completion of the reexamination. (Dkt. No. 21.) On January 3, 2017, MyGo
14
filed a non-opposition regarding the motion to stay. (Dkt. No. 23.)
15
LEGAL STANDARD
“A patent is presumed to be valid, and this presumption only can be overcome by
16
17
clear and convincing evidence to the contrary.” Enzo Biochem, Inc. Gen–Probe Inc., 424
18
F.3d 1276, 1281 (Fed. Cir. 2005) (citation omitted). However, “[a]ny person at any time
19
may file a request for reexamination by the [PTO] of any claim of a patent on the basis of
20
any prior art.” 35 U.S.C. § 302. The PTO must then “determine whether a substantial
21
new question of patentability affecting any claim of the patent concerned is raised by the
22
request.” 35 U.S.C. § 303(a).
“Courts have inherent power to manage their dockets and stay proceedings,
23
24
including the authority to order a stay pending conclusion of a PTO reexamination.”
25
Ethicon, Inc. v. Quigg, 849 F.2d 1422, 1426–27 (Fed. Cir. 1988) (citations omitted); TPK
26
Touch Sols., Inc. v. Wintek Electro-Optics Corporation (“TPK”), No. 13-CV-02218-JST,
27
28
2
Under 35 U.S.C. § 303(a), the PTO has three months to respond to a reexamination request.
2
3:16-CV-2350-GPC-RBB
1
2013 WL 5289015 (N.D. Cal. Sept. 18, 2013). This District has recognized a “liberal
2
policy in favor of granting motions to stay proceedings pending the outcome of [PTO]
3
reexamination or reissuance proceedings.” Palomar Techs., Inc. v. Mrsi Sys., LLC, No.
4
15-CV-1484 JLS (KSC), 2016 WL 4496839, at *2 (S.D. Cal. June 14, 2016) (quoting
5
ASCII Corp. v. STD Entm’t USA, 844 F. Supp. 1378, 1381 (N.D. Cal. 1994)). However,
6
this District also maintains a “strong public policy favoring expeditious resolutions of
7
litigation.” LG Elecs., Inc. v. Eastman Kodak Co., No. 09-CV-0344H(BLM), 2009 WL
8
1468703, at *2 (S.D. Cal. May 26, 2009) (quoting Kahn v. Gen. Motors Corp., 889 F.2d
9
1078, 1080 (Fed. Cir. 1989)) (denying motion for discretionary stay).
10
“There is no per se rule that patent cases should be stayed pending reexaminations,
11
because such a rule ‘would invite parties to unilaterally derail’ litigation.” Tokuyama
12
Corp. v. Vision Dynamics, LLC (“Tokuyama”), No. C082781SBA, 2008 WL 4532565, at
13
*2 (N.D. Cal. Oct. 9, 2008) (quoting Soverain Software LLC v. Amazon.Com, Inc., 356 F.
14
Supp. 2d 660, 662 (E.D. Tex. 2005)). “A court is under no obligation to delay its own
15
proceedings on account of a PTO patent reexamination, regardless of their relevancy to
16
infringement claims which the court must analyze.” Tric Tools, Inc. v. TT Techs., Inc.
17
(“Tric Tools”), 2012 WL 5289409, at *1 (N.D. Cal. Oct. 25, 2012), on reconsideration,
18
2012 WL 6087483 (N.D. Cal. Dec. 6, 2012) (citing Viskase Corp. v. Am. Nat’l Can Co.,
19
261 F.3d 1316, 1328 (Fed. Cir. 2001)). “‘The proponent of a stay bears the burden of
20
establishing its need.’” Presidio Components, Inc. v. Am. Tech. Ceramics Corp., No. 14-
21
CV-2061-H (BGS), 2015 WL 12843919, at *2 (S.D. Cal. Oct. 5, 2015) (quoting Clinton
22
v. Jones, 520 U.S. 681, 708 (1997)).
23
Courts consider three factors in determining whether to grant a stay pending
24
reexamination: “(1) whether discovery is complete and whether a trial date has been set;
25
(2) whether a stay will simplify the issues in question and trial of the case; and (3)
26
whether a stay would unduly prejudice or present a clear tactical disadvantage to the
27
nonmoving party.” Telemac Corp. v. Teledigital, Inc. (“Telemac”), 450 F. Supp. 2d
28
1107, 1111 (N.D. Cal. 2006) (citing In re Cygnus Telecom. Tech., LLC Patent Litig., 385
3
3:16-CV-2350-GPC-RBB
1
F. Supp. 2d 1022, 1023 (N.D. Cal. 2005)).
2
3
4
DISCUSSION
A. Stage of Litigation
The first factor considers whether discovery is complete and whether a trial date
5
has been set. “‘The early stage of a litigation weighs in favor of a stay pending
6
reexamination.’” Palomar Techs., Inc. v. Mrsi Sys., LLC, No. 15-CV-1484 JLS (KSC),
7
2016 WL 4496839, at *2 (S.D. Cal. June 14, 2016) (quoting Wireless Recognition Techs.
8
v. A9.com Inc., No. 5:12-CV-01217-EJD et al., 2012 WL 4005459, at *2 (N.D. Cal. Sept.
9
11, 2012)).
10
Here, the Complaint was filed approximately four months ago. (Dkt. No. 1.)
11
Discovery has commenced, but only limited document exchange has occurred between
12
the parties. (Dkt. No. 21-1 at 12:16–28.) No claim construction proceedings have begun,
13
and no trial date has been set. (Id.)
14
15
16
Accordingly, the relatively early stage of litigation weighs in favor of a stay.
B. Simplification of Issues
The second factor considers whether a stay is likely to simplify the issues in
17
litigation. MBI asserts that a stay pending reexamination will “simplify the issues of
18
invalidity and potentially narrow the claims,” will afford the Court the PTO’s expertise,
19
and will spare the parties and the Court the expense of claim construction proceedings.
20
(Id. at 14:9–20.) MBI relies on PTO statistics to support this claim, citing the likelihood
21
that the PTO will grant MBI’s request and that a reexamination will result in modification
22
of claims. (Dkt. No. 21-1, Ex. 2 at 3.)
23
MBI’s argument, however, assumes the PTO will grant the reexamination request.
24
(Dkt. No. 21-1 at 15:3–8.) See Ultra Prod., Inc. v. Antec, Inc. (“Antec”), No. C 09-04255
25
RS, 2010 WL 1688538, at *4 (N.D. Cal. Apr. 26, 2010) (“Especially where the PTO has
26
not yet granted the reexamination request, [movant] has not persuasively demonstrated
27
that the results of reexamination will simplify the instant litigation”). MBI has only
28
submitted a request for reexamination. The PTO has not granted that request. Whether
4
3:16-CV-2350-GPC-RBB
1
any PTO proceedings will even go forward remains to be seen. The Court therefore finds
2
that MBI’s motion to stay is premature.
3
Additionally, even if the PTO grants the reexamination request, there is no
4
guarantee that the patent will be canceled, its claims will be modified, or that any
5
modification will simplify the litigation. “‘The reexamination process considers only the
6
validity of the subject patent with regard to prior art; the PTO does not analyze
7
counterclaims or other grounds for patent invalidity.’” Tric Tools, 2012 WL 5289409 at
8
*2 (quoting ADA Solutions, Inc. v. Engineered Plastics, Inc., 826 F. Supp. 2d 348, 351
9
(D. Mass. 2011)); see also TPK, 2013 WL 5289015 at *3 (noting the limited scope of ex
10
parte reexaminations). MBI made multiple invalidity arguments in its counterclaims that
11
extend beyond the issue of prior art, including allegations of inequitable conduct and
12
fraud on the PTO. (Dkt. No. 7 at 1.) Ex parte reexamination would not address, let alone
13
simplify, such issues for the Court.
14
Furthermore, because MBI requested ex parte reexamination, as opposed to inter
15
partes reexamination, any PTO findings would have no estoppel effect on MBI with
16
respect to later litigation. See 35 U.S.C. § 315(e)(2); AT&T Intellectual Prop. I v. Tivo,
17
Inc., 774 F. Supp. 2d 1049, 1053 (N.D. Cal. 2011). Ex parte reexaminations involve an
18
independent review by the PTO, whereas inter partes reexaminations allow the parties to
19
participate more actively in the review process.3 Thus, a petitioner in an inter partes
20
reexamination is estopped from asserting invalidity arguments in subsequent litigation
21
that it could have raised during the administrative review process. 35 U.S.C. § 315(e)(2).
22
In contrast, no such estoppel provision exists for ex parte reexaminations. TPK, 2013
23
WL 6021324 at *3. Thus, even a successful and thorough ex parte reexamination would
24
not preclude MBI from litigating the same invalidity contentions asserted in the instant
25
case.
26
27
3
28
For example, in inter partes reexaminations, the parties are entitled to an oral hearing and may conduct
limited discovery and present evidence. 35 U.S.C. § 316(a).
5
3:16-CV-2350-GPC-RBB
1
2
Due to the prematurity of the motion and the uncertainty regarding simplification
of issues, the Court finds that this factor weighs against a stay.
3
C. Prejudice
4
The final factor considers whether a stay will unduly prejudice or produce a clear
5
tactical disadvantage to the non-moving party. MBI asserts that a stay will not prejudice
6
MyGo, but rather will save cost and effort for both parties, because only limited
7
discovery has been produced, and claim construction has not yet begun. (Dkt. No. 21-1
8
at 15:22–16:23.) It is true that MBI filed the reexamination request and motion to stay in
9
a timely manner after Plaintiff filed the Complaint and before discovery advanced beyond
10
its early stages. However, the Court already accounted for this timing consideration
11
supra in its analysis of the stage of litigation factor. The Court finds that other
12
considerations tip the balance of the prejudice factor against a stay, or at minimum leave
13
this factor neutral.
14
Most importantly, as the Court has emphasized above, MBI’s motion is premature.
15
Because the PTO has not granted or responded to MBI’s request at all, a stay would
16
prematurely and prejudicially delay litigation with no guarantee that any reexamination
17
will occur. See, e.g., Antec, 2010 WL 1688538 at *1 (finding prejudice in part because
18
the PTO had not granted the reexamination request); Tokuyama Corp. v. Vision
19
Dynamics, LLC, 2008 WL 4532565, at *1 (N.D. Cal. Oct. 9, 2008) (“That no PTO
20
proceedings are underway creates a delay to the plaintiffs which is prejudicial.”).4 Thus,
21
the Court is not prepared, nor required, to stall litigation when the PTO could deny the
22
reexamination request altogether. See Tric Tools, 2012 WL 5289409 at *1.
23
24
Additionally, the prejudice of prematurely delaying litigation is compounded by
the fact that MBI and MyGo are direct competitors in the sale of the product at issue.
25
26
27
28
4
The Court acknowledges that other courts have found differently. See, e.g., Graphon Corp. v. Juniper
Networks, Inc., No. C 10-1412 JSW, 2010 WL 3619579, at *2 (N.D. Cal. Sept. 13, 2010) (granting
motion to stay even though the PTO had not yet granted the reexamination request). However, the
existence of decisions on both sides is demonstrative of the Court’s discretion in this respect.
6
3:16-CV-2350-GPC-RBB
1
(See Dkt. No. 1 at ¶¶ 8–10.) See Allergan Inc. v. Cayman Chemical Co., 2009 WL
2
8591844 at *1 (C.D. Cal. 2009) (denying stay partly because parties were direct
3
competitors). “Unlike patent infringement actions involving non-practicing entities,
4
infringement among competitors can cause harm in the marketplace that is not
5
compensable by readily calculable money damages.” Avago Tech. Fiber IP (Singapore)
6
Pte. Ltd. v. IPtronics Inc., No. 10–cv–02863–EJD, 2011 WL 3267768, at *5 (N.D. Cal.
7
July 28, 2011) (citing Acumed LLC v. Stryker Corp., 551 F.3d 1323, 1327–28 (Fed. Cir.
8
2008)).
9
The Court acknowledges that MyGo has not opposed MBI’s motion to stay.
10
However, considering the fact that other considerations weigh against a stay, MyGo’s
11
non-opposition at most neutralizes the prejudice factor. Therefore, the Court finds that
12
the prejudice factor does not weigh in favor of a stay.
13
In sum, the first factor weighs in favor of a stay; the second factor weighs against a
14
stay; and the final factor weighs against a stay or is neutral at best. The movant bears the
15
burden to show the need for a stay, and the balance of the factors does not affirmatively
16
show such a need. In light of the Court’s discretion and the applicable law, the Court
17
declines to stay the case.
18
CONCLUSION
19
For the foregoing reasons, the Court DENIES Defendant MBI’s motion to stay.
20
IT IS SO ORDERED.
21
Dated: January 31, 2017
22
23
24
25
26
27
28
7
3:16-CV-2350-GPC-RBB
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?